Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Poxvirus vectors.

Kreijtz JH, Gilbert SC, Sutter G.

Vaccine. 2013 Sep 6;31(39):4217-9. doi: 10.1016/j.vaccine.2013.06.073. Epub 2013 Jul 5. No abstract available.

PMID:
23834812
2.

Adenovirus vectors as recombinant viral vaccines.

Imler JL.

Vaccine. 1995 Sep;13(13):1143-51. Review.

PMID:
8578797
3.

Adenovirus-based expression vectors and recombinant vaccines.

Graham FL, Prevec L.

Biotechnology. 1992;20:363-90. Review. No abstract available.

PMID:
1318139
4.

Poxvirus vector-based HIV vaccines.

Pantaleo G, Esteban M, Jacobs B, Tartaglia J.

Curr Opin HIV AIDS. 2010 Sep;5(5):391-6. doi: 10.1097/COH.0b013e32833d1e87. Review.

PMID:
20978379
5.

Vaccinia virus vectors.

Moss B.

Biotechnology. 1992;20:345-62. Review. No abstract available.

PMID:
1600384
6.

Chimeric virus-like particles as vaccines.

Kr├╝ger DH, Ulrich R, Gerlich WH.

Biol Chem. 1999 Mar;380(3):275-6. No abstract available.

PMID:
10223328
7.

Virology. New vaccine and treatment excite Ebola researchers.

Enserink M.

Science. 2003 Nov 14;302(5648):1141-2. No abstract available.

PMID:
14615510
8.

Poxviruses as vaccine vectors.

Pastoret PP, Vanderplasschen A.

Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):343-55. Review.

PMID:
12818621
9.

The promise and challenge of vaccinia-vectored vaccines.

Murphy FA.

Res Virol. 1989 Sep-Oct;140(5):463-5. No abstract available.

PMID:
2587851
10.

Update on HIV vaccines.

Meldorf M, Corey L.

STEP Perspect. 1997 Summer;9(2):5-6, 8-9.

PMID:
11364929
11.

Safe and effective poxvirus vectors--NYVAC and ALVAC.

Paoletti E, Tartaglia J, Taylor J.

Dev Biol Stand. 1994;82:65-9. Review.

PMID:
7958484
12.

Risks and benefits of vaccinia-vectored vaccine from the regulatory perspective.

Marcus-Sekura CJ, Quinnan GV Jr.

Res Virol. 1989 Sep-Oct;140(5):467-9; discussion 487-91. No abstract available.

PMID:
2685956
13.

Recombinant viruses as vaccines and immunological tools.

Rolph MS, Ramshaw IA.

Curr Opin Immunol. 1997 Aug;9(4):517-24. Review.

PMID:
9287173
14.

Poxvirus recombinant vaccines.

Paoletti E.

Ann N Y Acad Sci. 1990;590:309-25. Review.

PMID:
2198832
15.

Limited infection upon human exposure to a recombinant raccoon pox vaccine vector.

Rocke TE, Dein FJ, Fuchsberger M, Fox BC, Stinchcomb DT, Osorio JE.

Vaccine. 2004 Jul 29;22(21-22):2757-60.

PMID:
15246608
16.

Recent developments in the design of viral vaccines.

Minor PD.

Dev Biol Stand. 1996;87:51-7. Review. No abstract available.

PMID:
8854002
17.

T-cell immunity generated by recombinant adenovirus vaccines.

Yang TC, Millar JB, Grinshtein N, Bassett J, Finn J, Bramson JL.

Expert Rev Vaccines. 2007 Jun;6(3):347-56. Review.

PMID:
17542750
18.

Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting.

Chambers TJ, Tsai TF, Pervikov Y, Monath TP.

Vaccine. 1997 Oct;15(14):1494-502. No abstract available.

PMID:
9330458
19.

Regulation of poxvirus vectored vaccines.

Robertson JS.

Vaccine. 2013 Sep 6;31(39):4259-60. doi: 10.1016/j.vaccine.2013.05.092. Epub 2013 Jun 5. No abstract available.

PMID:
23747453
20.

Novel vaccines: bridging research, development and production - CHI's Inaugural Conference.

Ulmer JB.

IDrugs. 2006 Oct;9(10):696-8. No abstract available.

PMID:
17016775

Supplemental Content

Support Center